Literature DB >> 27074727

The type of preoperative biliary drainage predicts short-term outcome after major hepatectomy.

Yoji Kishi1, Kazuaki Shimada2, Satoshi Nara2, Minoru Esaki2, Tomoo Kosuge2.   

Abstract

PURPOSE: Endoscopic nasobiliary drainage (ENBD) is increasingly preferred to percutaneous transhepatic biliary drainage (PTBD) for patients undergoing major hepatectomy including hemihepatectomy or trisectorectomy with extrahepatic bile duct resection. The study was aimed to evaluate whether postoperative outcomes differed according to the types of biliary drainage.
METHODS: Patients who underwent major hepatectomy with bile duct resection for biliary tract cancer between December 2000 and March 2015 were classified into four groups according to their initial biliary drainage type. The preoperative management and postoperative morbidity were compared.
RESULTS: Totally, 280 patients were classified into the following groups: no biliary drainage (n = 109), PTBD (n = 99), ENBD (n = 28), and endoscopic retrograde biliary drainage (ERBD; n = 44). Preoperative catheter management including tube exchange or additional tube placement due to cholangitis or poor drainage was most frequently required in the ERBD group (PTBD, 18 %; ENBD, 14 %; ERBD, 43 %; P < 0.01). By the time of hepatectomy, 141 patients underwent at least one PTBD (PTBD(+)) and 30 patients were managed only with endoscopic biliary drainage (PTBD(-)). The incidence of major postoperative morbidities (Clavien-Dindo grade ≥ III) in PTBD(+) and PTBD(-) group was 23 and 3 %, respectively (P = 0.01). A multivariate analysis among 171 patients with biliary drainage showed PTBD(+) (P = 0.04; odds ratio = 8.50; 95 % confidential interval [CI], 1.10-65.45) and red blood cells transfusion (P < 0.01; odds ratio = 2.72; 95 % CI, 1.22-6.09) were independent predictors of major morbidity.
CONCLUSION: The type of preoperative biliary drainage was associated with the perioperative outcomes of major hepatectomy. Sticking to endoscopic biliary drainage was associated with lower risk of postoperative major morbidity.

Entities:  

Keywords:  Endoscopic nasobiliary drainage; Endoscopic retrograde biliary drainage; Major hepatectomy with extrahepatic bile duct resection; Percutaneous transhepatic biliary drainage; Preoperative biliary drainage

Mesh:

Year:  2016        PMID: 27074727     DOI: 10.1007/s00423-016-1427-y

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  33 in total

1.  Effect of preoperative biliary drainage on surgical outcome after pancreatoduodenectomy.

Authors:  M E Martignoni; M Wagner; L Krähenbühl; C A Redaelli; H Friess; M W Büchler
Journal:  Am J Surg       Date:  2001-01       Impact factor: 2.565

2.  A matched case-control study of preoperative biliary drainage in patients with pancreatic adenocarcinoma: routine drainage is not justified.

Authors:  James J Mezhir; Murray F Brennan; Raymond E Baser; Michael I D'Angelica; Yuman Fong; Ronald P DeMatteo; William R Jarnagin; Peter J Allen
Journal:  J Gastrointest Surg       Date:  2009-09-23       Impact factor: 3.452

Review 3.  Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy.

Authors:  S P Povoski; M S Karpeh; K C Conlon; L H Blumgart; M F Brennan
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

4.  Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

Authors:  Nuh N Rahbari; O James Garden; Robert Padbury; Mark Brooke-Smith; Michael Crawford; Rene Adam; Moritz Koch; Masatoshi Makuuchi; Ronald P Dematteo; Christopher Christophi; Simon Banting; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yukihiro Yokoyama; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Lorenzo Capussotti; Markus W Büchler; Jürgen Weitz
Journal:  Surgery       Date:  2011-01-14       Impact factor: 3.982

5.  Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer?

Authors:  Yoshihiro Sakamoto; Satoshi Nara; Yoji Kishi; Minoru Esaki; Kazuaki Shimada; Norihiro Kokudo; Tomoo Kosuge
Journal:  Surgery       Date:  2013-02-13       Impact factor: 3.982

6.  Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy and risk factors related to complications.

Authors:  Hiroki Kawashima; Akihiro Itoh; Eizaburo Ohno; Yuya Itoh; Tomoki Ebata; Masato Nagino; Hidemi Goto; Yoshiki Hirooka
Journal:  Ann Surg       Date:  2013-01       Impact factor: 12.969

7.  Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.

Authors:  Sung Gyu Lee; Gi Won Song; Shin Hwang; Tae Yong Ha; Deok Bog Moon; Dong Hwan Jung; Ki Hun Kim; Chul Soo Ahn; Myung Hwan Kim; Sung Koo Lee; Kyu Bo Sung; Gi Young Ko
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-10-23       Impact factor: 7.027

8.  Left hepatic trisectionectomy for advanced perihilar cholangiocarcinoma.

Authors:  M Esaki; K Shimada; S Nara; Y Kishi; Y Sakamoto; T Kosuge; T Sano
Journal:  Br J Surg       Date:  2013-03-04       Impact factor: 6.939

9.  Negligible effect of selective preoperative biliary drainage on perioperative resuscitation, morbidity, and mortality in patients undergoing pancreaticoduodenectomy.

Authors:  Jodi M Coates; Shannon H Beal; Jack E Russo; Kimberly A Vanderveen; Steven L Chen; Richard J Bold; Robert J Canter
Journal:  Arch Surg       Date:  2009-09

10.  Preoperative biliary drainage for biliary tract and ampullary carcinomas.

Authors:  Masato Nagino; Tadahiro Takada; Masaru Miyazaki; Shuichi Miyakawa; Kazuhiro Tsukada; Satoshi Kondo; Junji Furuse; Hiroya Saito; Toshio Tsuyuguchi; Tatsuya Yoshikawa; Tetsuo Ohta; Fumio Kimura; Takehiro Ohta; Hideyuki Yoshitomi; Satoshi Nozawa; Masahiro Yoshida; Keita Wada; Hodaka Amano; Fumihiko Miura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-02-16
View more
  6 in total

Review 1.  How to Choose Between Percutaneous Transhepatic and Endoscopic Biliary Drainage in Malignant Obstructive Jaundice: An Updated Systematic Review and Meta-analysis.

Authors:  Alessandro Rizzo; Angela Dalia Ricci; Giorgio Frega; Andrea Palloni; Stefania DE Lorenzo; Francesca Abbati; Veronica Mollica; Simona Tavolari; Mariacristina DI Marco; Giovanni Brandi
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

2.  The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors.

Authors:  James R Howe; Nipun B Merchant; Claudius Conrad; Xavier M Keutgen; Julie Hallet; Jeffrey A Drebin; Rebecca M Minter; Terry C Lairmore; Jennifer F Tseng; Herbert J Zeh; Steven K Libutti; Gagandeep Singh; Jeffrey E Lee; Thomas A Hope; Michelle K Kim; Yusuf Menda; Thorvardur R Halfdanarson; Jennifer A Chan; Rodney F Pommier
Journal:  Pancreas       Date:  2020-01       Impact factor: 3.327

3.  Impact Factors for Perioperative Morbidity and Mortality and Repercussion of Perioperative Morbidity and Long-term Survival in Pancreatic Head Resection.

Authors:  Stojan Potrc; Arpad Ivanecz; Vid Pivec; Urska Marolt; Sasa Rudolf; Bojan Iljevec; Tomaz Jagric
Journal:  Radiol Oncol       Date:  2017-09-14       Impact factor: 2.991

Review 4.  Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology.

Authors:  Enrico Gringeri; Martina Gambato; Gonzalo Sapisochin; Tommy Ivanics; Erica Nicola Lynch; Claudia Mescoli; Patrizia Burra; Umberto Cillo; Francesco Paolo Russo
Journal:  J Clin Med       Date:  2020-05-05       Impact factor: 4.241

5.  Preoperative biliary drainage in hilar cholangiocarcinoma: when and how?

Authors:  Horst Neuhaus
Journal:  Endosc Int Open       Date:  2020-01-22

Review 6.  Internal drainage versus external drainage in palliation of malignant biliary obstruction: a meta-analysis and systematic review.

Authors:  Xiaopeng Tian; Zixuan Zhang; Wen Li
Journal:  Arch Med Sci       Date:  2020-04-06       Impact factor: 3.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.